(+)-JQ1 and FeLV: viral DNA findings in two feline cell lines
Viruses · 2023
In plain language
This study used two feline cell lines grown in a laboratory, not live cats. With (+)-JQ1, one cell line showed a statistically significant reduction in viral DNA integrated into the cells; in the other, the reduction was not statistically significant. In that second cell line, the proportion of viral DNA that was not integrated increased significantly, a finding consistent with impaired integration but not proof of that mechanism. The results do not demonstrate removal of viral DNA already integrated into cells or elimination of persistent reservoirs, and they do not establish what happens in infected cats.
Scientific detail
The study published in Viruses in 2023 (doi: 10.3390/v15091853) investigated the BET inhibitor (+)-JQ1 against FeLV in vitro in two feline cell lines, 81C and 3201. The methods specify three biological replicate samples for each treatment and collection timepoint in 81C, and biological triplicate experiments in 3201. The total number of experimental samples was not reported. The claims in the supplied object are classified as evidence level D.
In FeLV-challenged 81C cultures, (+)-JQ1 significantly reduced feline-albumin-normalized proviral loads at concentrations of 125 and 500 nM at 48, 72, and 192 h post-infection compared with enantiomer and untreated controls. This establishes a lower measured proviral load under those experimental conditions; it does not demonstrate excision of previously integrated proviruses or clearance of infection.
In FeLV-exposed 3201 cells, the lower normalized proviral load observed with 500 nM (+)-JQ1 was not statistically significant. By contrast, at that concentration, the proportion of unintegrated FeLV DNA was significantly greater than in controls at 24 h post-infection. This is a relative measurement consistent with impaired integration; it does not directly identify unintegrated DNA species or establish an absolute increase in their copy number. Integration was assessed using nested PCR and relative DNA measurements, so the proposed causal mechanism remains an interpretation of the results.
The authors identify studies in additional cell lines as necessary because of FeLV's broad cell tropism and call for further in vivo investigations. The findings in 81C and 3201 do not establish equivalent effects across all FeLV-susceptible feline cell types, elimination of persistent reservoirs, or outcomes in infected cats. The Discussion notes limited oral bioavailability and a short in vivo terminal elimination half-life for (+)-JQ1. Figures and supplementary data referenced in the text were not included in the supplied content.
What we know
The level D in vitro evidence shows a significant reduction in normalized proviral load in 81C under the conditions described. In 3201, the reduction in normalized proviral load was not significant, but the relative proportion of unintegrated viral DNA did increase significantly at 24 h with 500 nM (+)-JQ1. These findings support a possible BET-dependent integration step without establishing the causal mechanism.
What we don't know
Whether these effects occur in other feline cell types or in infected cats has not been established. Removal of previously integrated proviruses and elimination of persistent reservoirs have not been demonstrated either. The relative unintegrated-DNA measurement cannot establish an absolute increase in copy number or directly identify the DNA species involved. The total number of experimental samples was not reported, and figures and supplementary data were unavailable in the supplied content.
Evidence
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 100/100
In FeLV-exposed 3201 cells, the lower normalized proviral load observed with 500 nM (+)-JQ1 was not statistically significant.
Excerpt verified in the source — verbatim, in the source's own language“Although not statistically significant, the fALB-normalized FeLV proviral load in 500 nM (+)-JQ1-treated, FeLV-exposed 3201 cells trended lower compared to controls at all measured timepoints ( Figure 4 a).”
The 3201 proviral-load endpoint must not be described as a statistically significant reduction. It is distinct from the significant change in the relative unintegrated-DNA endpoint.
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 100/100
In FeLV-challenged 81C cultures, (+)-JQ1 significantly reduced feline-albumin-normalized proviral loads at 125 and 500 nM at 48, 72, and 192 h post-infection compared with enantiomer and untreated controls.
Excerpt verified in the source — verbatim, in the source's own language“Significant dose-dependent decreases in fALB-normalized FeLV proviral loads of 81C cell cultures treated with 125 nM and 500 nM (+)-JQ1 and challenged with FeLV were observed at 48, 72, and 192 hpi compared to enantiomer and untreated controls ( Figure 2 a).”
This establishes a lower measured proviral load under the experimental conditions. It does not demonstrate excision of existing integrated proviruses or clearance of infection.
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 100/100
The authors identify testing additional cell lines as necessary because FeLV has broad cell tropism.
Excerpt verified in the source — verbatim, in the source's own language“Due to broad FeLV cell tropism, the effects of BETi on FeLV infection in additional cell lines should be assessed.”
The findings from 81C and 3201 do not establish that BET inhibition has equivalent effects across all FeLV-susceptible feline cell types.
EvidenceLevel D — Indirect evidence: other species or retrovirusConfidence 100/100
In 3201 cells exposed to 500 nM (+)-JQ1, the proportion of unintegrated FeLV DNA was significantly greater than in controls at 24 h post-infection.
Excerpt verified in the source — verbatim, in the source's own language“The proportion of unintegrated FeLV DNA in 3201 cells treated with 500 nM (+)-JQ1 was significantly greater at 24 hpi compared to controls ( Figure 4 b).”
This relative DNA measurement is consistent with impaired integration. It does not directly identify unintegrated DNA species or establish an absolute increase in their copy number.
Provenance
Source: BET Inhibitor JQ1 Attenuates Feline Leukemia Virus DNA, Provirus, and Antigen Production in Domestic Cat Cell Lines.
AVA